When University of Zimbabwe medical student Natasha Faith Chikosha closes her eyes, she does not first remember lecture theatres, anatomy textbooks or the sterile scent of hospital corridors.
She remembers her mother.
She remembers a household learning to live with diabetes and a young girl forced to become dependable before she had fully learned how to be a child.
Most of all, she remembers the doctors who brought calm into rooms filled with fear.
“They could reassure people,” Natasha says softly. “I liked how doctors solved problems. I also wanted to be that voice for someone deep in the tunnel.”
It is a dream she nurtured long before cancer entered her own life.
At 24, Natasha was nearing the finish line of a journey she had spent years pursuing. A sixth-year medical student at the University of Zimbabwe, she had survived sleepless nights, demanding clinical rotations and the pressures of studying medicine in a healthcare system strained by economic challenges.
She was preparing to save lives.
Now she is fighting to save her own.
The first signs were deceptively ordinary. A dull ache that she initially dismissed as fatigue from long hours on hospital wards. Like many medical students, she pushed through the discomfort and carried on.
But the pain intensified.
“It became unbearable,” she recalls. “By the third day I could hardly sit down. Nights were the worst.”
A CT scan at a private clinic revealed enlarged lymph nodes. A biopsy followed, then the agonising wait for histology and immunohistochemistry results.
As a medical student, Natasha understood what some of the warning signs could mean. The uncertainty was almost as frightening as the diagnosis itself.
When the results finally arrived, she was already admitted to WestEnd Hospital because the pain could no longer be managed at home.
The verdict was devastating: ALK-negative anaplastic large cell lymphoma, a rare and aggressive form of non-Hodgkin lymphoma that requires urgent specialised treatment.
“I wasn’t completely surprised,” she says quietly. “But my family and friends were shocked.”
Life immediately split into two chapters: before cancer and after cancer.
Before cancer, Natasha was a runner who greeted each morning with exercise before heading to hospital. Before cancer, she could spend hours on her feet during clinical rounds. Before cancer, her future seemed clear.
Now, even walking short distances can leave her struggling.
“I used to run every morning,” she says. “Now sometimes I can’t even walk a kilometre.”
Three chemotherapy sessions have already taken a heavy toll. Fatigue dominates her days. Concentration fades while reading. Some mornings she cannot get out of bed. Her life now revolves around treatment schedules, pain management and recovery between cycles.
Yet Natasha says cancer affects far more than the patient.
“Big medical diagnoses affect the whole family,” she says. “It becomes a family disease more than an individual one.”
In a painful reversal of roles, the daughter who once helped care for her diabetic mother is now the one being monitored, medicated and comforted.
The caregiver has become the patient.
Then comes another challenge: the public struggle for survival.
To access life-saving treatment, Natasha’s family has had to transform private suffering into public appeals. Fundraising posters circulate on social media. Relatives repeatedly share donation details and plead for assistance from strangers.
“There are well-wishers,” Natasha says. “But there are also unsolicited comments. It adds to the emotional drain.”
The treatment she urgently needs is brentuximab vedotin, marketed as Adcetris, a targeted therapy that has significantly improved outcomes for patients with certain forms of lymphoma, including anaplastic large cell lymphoma.
For patients like Natasha, the drug offers a genuine chance at remission and long-term survival.
But hope comes at a staggering cost.
The family hopes to source the medication in India, where treatment expenses are projected to reach approximately US$40,000 — a figure beyond the reach of most Zimbabwean families.
Her fundraising flyer has become both a symbol of hope and a reminder of the harsh inequalities that define access to healthcare.
The image is striking in its simplicity: Natasha in medical scrubs, a stethoscope around her neck, smiling confidently.
She looks exactly like the doctor she was becoming.
The appeal reads: “Together we can give Natasha a fighting chance and help her become a doctor.”
Behind those words lies a painful reality. A young woman who dedicated her life to healing others must now rely on the generosity of strangers to access treatment that already exists.
Yet even amid pain, uncertainty and financial hardship, Natasha continues to dream beyond herself.
“Before the diagnosis I wanted to become a physician,” she says. Then she pauses.
“Now I’m thinking maybe oncology.”
Why?
“Because there’s a gap there. There’s more impact and awareness that can go into that field.”
Even now, she is thinking about other patients. Other frightened families. Other people searching for hope in their darkest moments.
Friends describe her as resilient, ambitious and compassionate — the kind of student who stayed behind after ward rounds to help others understand difficult concepts.
Today, those same friends are organising fundraising campaigns, sharing donation links and searching desperately for resources that could buy her more time.
Because in oncology, time is everything.
Time for another cycle.
Time for another scan.
Time for another chance at remission.
Time to complete medical school and return to the wards where she belongs.
Amid the devastation, there are still victories worth celebrating: a day with less pain, a short walk completed successfully, a good night's sleep, a friend's visit that brings laughter into an otherwise difficult week.
These are the moments cancer patients learn to treasure.
“I still want to be that voice,” Natasha says. “The one for people deep in the tunnel.”
The irony is impossible to ignore. Today, Natasha speaks from inside that tunnel herself.
Yet her instinct remains unchanged — to guide others toward the light even while fighting her own battle.
The Chikosha family continues appealing for assistance through EcoCash, InnBucks, AgriBank accounts and international crowdfunding platforms. Their goal is urgent: secure access to brentuximab vedotin before the window for effective treatment narrows.
Behind every donation appeal is a simple truth.
This is a young woman standing at the edge of the life she worked tirelessly to build.
A future doctor trying desperately not to become a statistic.
And long after the pathology reports, treatment schedules and fundraising targets are forgotten, one image will endure:
Natasha in scrubs. Small against the vast machinery of illness and inequality. Still smiling. Still believing she will one day walk hospital corridors again — not as a patient, but as the doctor offering hope to someone else.
“I might lean toward oncology,” she says again. “Because there’s so much more impact and awareness that can go into that field.”
The question now is whether society will help make that future possible.